Skip to content
★ Sign in to follow
KE

Kenneth E. Jones

Total declarations
77
Companies
2
▲ Purchases (2 ops.)
€984k
▼ Sales (65 ops.)
€2.7M

Latest filing published 23 Jul 2009 for LIFECORE BIOMEDICAL, INC. \DE\.

Insider track record

Disclosed buys
2
Disclosed sells
65
Signal history

No signal scores available.

Closed purchases

Market purchases
2
Positive at T+90
0%
Median T+90
-13.4%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 19 May 2008 · 6747 days ago · €696k
    -70.5%
    Entry US$44.70 · Close at T+365 US$13.20

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Kenneth E. Jones: trading record in brief

Filings by Kenneth E. Jones span 2 companies, the busiest being Lifecore Biomedical, Inc. \DE\ and Globalstar, Inc. In total, 77 filings cover trades dated from 9 May 2007 to 22 July 2009.

On the open market, the record shows 2 purchases worth €984k and 65 sales worth €2.7M. On balance, insiders were net sellers of €1.7M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 4 share grants and 6 option exercises.

The newest entry dates from 23 July 2009: an option exercise, in Lifecore Biomedical, Inc. \DE\. The clock since the last published purchase (19 May 2008) now reads 6,747 days. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Kenneth E. Jones

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations76 total

25 of 76 declarations